In which patients with candiduria is fluconazole indicated, and what are the appropriate dosing regimens for uncomplicated versus upper urinary tract infection?

Fluconazole for Candiduria: Indications and Dosing

Most patients with candiduria do NOT require antifungal treatment—fluconazole is indicated only for high-risk patients (neutropenic, very low-birth-weight infants <1500g, or those undergoing urologic procedures), symptomatic cystitis, or pyelonephritis with fluconazole-susceptible organisms. 1

When NOT to Treat

The IDSA guidelines are explicit: asymptomatic candiduria should NOT be treated with antifungal agents unless the patient is at high risk for dissemination 1. The primary intervention should be:

• Remove indwelling bladder catheters whenever feasible (strong recommendation) 1
• This alone achieves 87-93% clearance of candiduria at 8 weeks 2

High-Risk Patients Requiring Treatment

Treatment is indicated for three specific groups 1:

1. Neutropenic patients → Treat as candidemia (echinocandin or lipid formulation amphotericin B)
2. Very low-birth-weight infants (<1500g) → Treat as candidemia
3. Patients undergoing urologic procedures → Fluconazole 400 mg (6 mg/kg) daily OR amphotericin B deoxycholate 0.3-0.6 mg/kg daily for several days before and after the procedure

Symptomatic Candida Cystitis

For fluconazole-susceptible organisms (primarily C. albicans):

• Fluconazole 200 mg (3 mg/kg) daily for 2 weeks (strong recommendation; moderate-quality evidence) 1
• Remove catheter if present 1

For fluconazole-resistant species:

• C. glabrata: Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days OR flucytosine 25 mg/kg 4 times daily for 7-10 days 1
• C. krusei: Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days 1
• Alternative: Amphotericin B bladder irrigation 50 mg/L sterile water daily for 5 days (weak recommendation) 1

Candida Pyelonephritis (Upper Tract Infection)

For fluconazole-susceptible organisms:

• Fluconazole 200-400 mg (3-6 mg/kg) daily for 2 weeks (strong recommendation) 1
• Note the higher dose range (up to 400 mg) compared to cystitis
• Eliminate urinary tract obstruction (strong recommendation) 1
• Consider removal/replacement of nephrostomy tubes or stents 1

For fluconazole-resistant species:

• C. glabrata: Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days with or without flucytosine 25 mg/kg 4 times daily 1
• Alternative: Flucytosine monotherapy 25 mg/kg 4 times daily for 2 weeks (weak recommendation) 1
• C. krusei: Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days 1

Critical Dosing Details from FDA Label

The FDA label confirms 3:

• Urinary tract infections: Daily doses of 50-200 mg have been used
• Systemic Candida infections: Doses up to 400 mg daily
• Oral and IV dosing are equivalent due to rapid, complete absorption
• Can be taken with or without food

Important Caveats

Species identification matters: Nearly half of candiduria cases are non-C. albicans species 4, with C. glabrata (19.7%) being particularly concerning due to fluconazole resistance. Always obtain susceptibility testing before initiating therapy.

Renal dysfunction considerations:

• Fluconazole requires dose adjustment for creatinine clearance ≤50 mL/min 3
• In patients with renal dysfunction, amphotericin B bladder irrigation may be superior to fluconazole 5
• Pretreatment serum creatinine inversely correlates with candiduria eradication 6

Recurrence is common: Even with fluconazole treatment achieving 50% eradication at day 14, long-term eradication rates are disappointing, with similar candiduria rates between treated and untreated patients at 2 weeks post-therapy 6. This reinforces that catheter removal is more important than antifungal therapy in most cases.

Echinocandins have limited utility: They achieve poor urinary concentrations and should not be used for isolated candiduria 7.